Tuesday, 21 January 2020

Drug Discovery News

  • Pfizer receives Breakthrough Therapy designation for inhibitor drug

    Drug Discovery |  News | 0 Comment | 06 Sep, 2018

    Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthrough Therapy designation from the U.S. Food and Drug Administration (...Read more

  • China approves first "Made in China" cancer drug

    Drug Discovery |  News | 0 Comment | 06 Sep, 2018

    China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the National Medical Products Administration of China (“NMPA”, f...Read more

  • BeiGene Announces Acceptance of its First NDA for Zanubrutinib

    Drug Discovery |  News | 0 Comment | 28 Aug, 2018

    China's commercial-stage biopharmaceutical company BeiGene,   recently announced the acceptance by the China Drug Administration (CDA) of a new drug application (NDA) fo...Read more

  • FDA approves first drug for neurotrophic keratitis

    Drug Discovery |  News | 0 Comment | 23 Aug, 2018

    Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear ...Read more

  • Strides Pharma receives USFDA nod for two key ANDAs

    Drug Discovery |  News | 0 Comment | 22 Aug, 2018

    India's Strides Pharma  has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, received ANDA “acceptable for filing” corre...Read more

  • GIC receives govt funding for immuno-oncology project

    Drug Discovery |  News | 0 Comment | 22 Aug, 2018

    Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) related...Read more

  • Roche's Alecensa receives 'priority review' designation from CNDA

    Drug Discovery |  News | 0 Comment | 21 Aug, 2018

    Roche  recently announced that the China National Drug Administration (CNDA) has granted marketing authorization for Alecensa (alectinib) as a monotherapy treatment for patients with a...Read more

  • HitGen collaborates with LG Chem

    Drug Discovery |  News | 0 Comment | 20 Aug, 2018

    HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small molecule leads for targets of interest. In this collaboration, HitGen ...Read more

  • Blueberry Therapeutics raises £10M funding to develop nanomedicines

    Drug Discovery |  News | 0 Comment | 16 Aug, 2018

    Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines for difficult to treat skin and nail infections, has successfully com...Read more

  • Multi- institutional alliance to develop anti-aging drugs

    Drug Discovery |  News | 0 Comment | 16 Aug, 2018

    The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial intelligence (AI) to discover and develop novel anti-aging therapeutics ...Read more

  • FDA approves Amicus' Galafold for Fabry disease

    Drug Discovery |  News | 0 Comment | 13 Aug, 2018

    Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indica...Read more

  • Pfizer's Innovative drug IBRANCE gets China approval

    Drug Discovery |  News | 0 Comment | 08 Aug, 2018

    Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbociclib) on July 31st, the first cyclin-dependent Kinase 4/6 (CDK4/6) inh...Read more

  • DotBio successfully raises $2.3 M in seed financing

    Drug Discovery |  News | 0 Comment | 07 Aug, 2018

    Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanized domain antibodies, has officially launched and has successfully rai...Read more

  • Medpacto inks deal with AstraZeneca

    Drug Discovery |  News | 0 Comment | 02 Aug, 2018

    MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto’s vactosertib (TEW-7197), a small molecule, oral inhibitor of ...Read more

  • Pfizer's Herceptin biosimilar approved in Europe

    Drug Discovery |  News | 0 Comment | 31 Jul, 2018

    Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cancer med Herceptin (trastuzumab). TRAZIMERA, a potential biosimilar to ...Read more

  • Nektar's back pain opioid gets approval for FDA review

    Drug Discovery |  News | 0 Comment | 30 Jul, 2018

     Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NKTR-181 for the treatment of chronic low back pain in adult patients n...Read more

  • Agios receives nod for ivosidenib

    Drug Discovery |  News | 0 Comment | 23 Jul, 2018

    Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult patients with relapsed/refractory acute myeloid leukemia (AML) with a sus...Read more

  • FDA approves Pfizer's biosimilar

    Drug Discovery |  News | 0 Comment | 23 Jul, 2018

    Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected to hit the market at a significant discount to its reference drug. Th...Read more



Survey Box

Is 2020 demanding timely action of technology adoption in healthcare?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls